{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:20:18Z","timestamp":1759962018153},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.patbio.2008.02.007","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T16:25:39Z","timestamp":1207326339000},"page":"220-228","source":"Crossref","is-referenced-by-count":5,"title":["Traitement de la maladie thromboembolique veineuse chez le canc\u00e9reux"],"prefix":"10.1016","volume":"56","author":[{"given":"D.","family":"Farge-Bancel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Florea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bosquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Debourdeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0248-8663(00)80046-6","article-title":"Maladie thromboembolique veineuse et cancer","volume":"21","author":"Sauve","year":"2000","journal-title":"Rev Med Interne"},{"issue":"15","key":"10.1016\/j.patbio.2008.02.007_bib3","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/archinte.165.15.1782","article-title":"Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults","volume":"165","author":"White","year":"2005","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.patbio.2008.02.007_bib4","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.2005.04.2150","article-title":"Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival","volume":"24","author":"Alcalay","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.patbio.2008.02.007_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the Medenox Study","volume":"164","author":"Ahkhan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.patbio.2008.02.007_bib6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"25","key":"10.1016\/j.patbio.2008.02.007_bib7","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2008.02.007_bib8","doi-asserted-by":"crossref","first-page":"401S","DOI":"10.1378\/chest.126.3_suppl.401S","article-title":"Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"B\u00fcller","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.patbio.2008.02.007_bib9","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.patbio.2008.02.007_bib10","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1200\/JCO.2007.14.1283","article-title":"American Society of Clinical Oncology Guideline: recommendations for venous thromboembolism prophylaxis and treatment in Patients With Cancer","volume":"25","author":"Lyman","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.critrevonc.2006.05.001","article-title":"Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM)","volume":"59","author":"Mandal\u00e0","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib12","first-page":"160","article-title":"The diagnosis and treatment of thrombosis in the cancer patient","volume":"17","author":"Levine","year":"1990","journal-title":"Semin Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.patbio.2008.02.007_bib13","doi-asserted-by":"crossref","first-page":"287S","DOI":"10.1378\/chest.126.3_suppl.287S","article-title":"Hemorrhagic complications of anticoagulant treatment: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Levine","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.patbio.2008.02.007_bib14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0038-1650643","article-title":"Risk factors for bleeding during treament of acute venous thromboemebolism","volume":"76","author":"Wester","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.02.007_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4065\/70.8.725","article-title":"Bleeding and thromboembolism during anticoagulant therapy: a population based study in Rochester, Minesota","volume":"70","author":"Gitter","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02016754","article-title":"Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement","volume":"5","author":"Calligaro","year":"1991","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1445-5994.1992.tb02789.x","article-title":"Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy","volume":"22","author":"Chan","year":"1992","journal-title":"Aust N Z J Med"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0248-8663(96)81247-1","article-title":"Classical anticoagulant treatment of venous thromboembolic disease in cancer patients. A retrospective study of 71 patients","volume":"17","author":"Debourdeau","year":"1996","journal-title":"Rev Med Interne"},{"issue":"12","key":"10.1016\/j.patbio.2008.02.007_bib19","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.amjmed.2006.02.022","article-title":"Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer","volume":"119","author":"Hull","year":"2006","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.patbio.2008.02.007_bib20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.1995.00430060059007","article-title":"Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis","volume":"155","author":"Lensing","year":"1995","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0002-9343(97)89484-3","article-title":"Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis","volume":"100","author":"Siragusa","year":"1996","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00063198-199807000-00007","article-title":"Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism","volume":"4","author":"Hettiarachchi","year":"1998","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.160.2.181","article-title":"A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency","volume":"160","author":"Dolovich","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.patbio.2008.02.007_bib24","first-page":"935","article-title":"Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis","volume":"85","author":"Rocha","year":"2000","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","article-title":"Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials","volume":"140","author":"Quinlan","year":"2004","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib26","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1378\/chest.128.4.2203","article-title":"Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis","volume":"128","author":"Mismetti","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1055\/s-0037-1615937","article-title":"Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread","volume":"82","author":"Hettiarachchi","year":"1999","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.patbio.2008.02.007_bib28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-130-10-199905180-00003","article-title":"Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials","volume":"130","author":"Gould","year":"1999","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.patbio.2008.02.007_bib29","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.patbio.2008.02.007_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00000421-200002000-00020","article-title":"Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis","volume":"23","author":"Bona","year":"2000","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.patbio.2008.02.007_bib31","first-page":"805","article-title":"A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy","volume":"84","author":"Palareti","year":"2000","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.patbio.2008.02.007_bib32","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib33","first-page":"296","article-title":"Treatment of deep vein thrombosis with oral anticoagulants in patients with malignancy: prospective cohort study","volume":"43","author":"Vuci\u0107","year":"2002","journal-title":"Croat Med J"},{"issue":"15","key":"10.1016\/j.patbio.2008.02.007_bib34","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","article-title":"Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study","volume":"162","author":"Meyer","year":"2002","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1076029606293692","article-title":"Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period","volume":"12","author":"Deitcher","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.patbio.2008.02.007_bib37","doi-asserted-by":"crossref","unstructured":"Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med 1997; 337(10):657\u201362.","DOI":"10.1056\/NEJM199709043371001"},{"issue":"11","key":"10.1016\/j.patbio.2008.02.007_bib38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199603143341102","article-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group","volume":"334","author":"Koopman","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.patbio.2008.02.007_bib39","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.130.6.1808","article-title":"Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?","volume":"130","author":"Ferretti","year":"2006","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.patbio.2008.02.007_bib40","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1046\/j.1538-7836.2003.00364.x","article-title":"Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants","volume":"1","author":"Iorio","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/0269216305pm1008oa","article-title":"Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study","volume":"19","author":"Noble","year":"2005","journal-title":"Palliat Med"},{"issue":"7541","key":"10.1016\/j.patbio.2008.02.007_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.38733.616065.802","article-title":"Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study","volume":"332","author":"Noble","year":"2006","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib43","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0002-8703(97)70041-3","article-title":"Attenuation over 24h of the efficacy of thrombolysis of pulmonary embolism among patients with cancer","volume":"134","author":"Mikkola","year":"1997","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ana.410130320","article-title":"Incidence and treatment of peripheral venous thrombosis in patients with glioma","volume":"13","author":"Ruff","year":"1983","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.patbio.2008.02.007_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-0038-1649592","article-title":"Venous thromboembolism and high grade gliomas","volume":"70","author":"Dhami","year":"1993","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.patbio.2008.02.007_bib46","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/1097-0142(19911215)68:12<2621::AID-CNCR2820681218>3.0.CO;2-7","article-title":"The incidence and significance of thromboembolic complications in patients with high-grade gliomas","volume":"68","author":"Cheruku","year":"1991","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0025-6196(12)62216-2","article-title":"Thromboembolism in patients with high-grade glioma","volume":"69","author":"Quevedo","year":"1994","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1227\/00006123-198002000-00004","article-title":"Incidence of lower extremity deep vein thrombosis in neurosurgical patients","volume":"6","author":"Valladares","year":"1980","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.patbio.2008.02.007_bib49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00063198-200109000-00013","article-title":"Thromboembolism in brain tumors","volume":"7","author":"Walsh","year":"2001","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"10.1016\/j.patbio.2008.02.007_bib50","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2005.04.6656","article-title":"Management of venous thromboembolism in patients with primary and metastatic brain tumors","volume":"24","author":"Gerber","year":"2006","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.patbio.2008.02.007_bib51","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00415-002-0855-5","article-title":"Low molecular weight heparin for deep vein thrombosis in glioma patients","volume":"249","author":"Schmidt","year":"2002","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.patbio.2008.02.007_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1227\/00006123-199007000-00010","article-title":"The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors","volume":"27","author":"Altschuler","year":"1990","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.patbio.2008.02.007_bib53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.43.6.1111","article-title":"Complications of therapy for venous thromboembolic disease in patients with brain tumors","volume":"43","author":"Levin","year":"1993","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.patbio.2008.02.007_bib54","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0142(19940115)73:2<493::AID-CNCR2820730240>3.0.CO;2-D","article-title":"Therapy of venous thromboembolism in patients with brain metastases","volume":"73","author":"Schiff","year":"1994","journal-title":"Cancer"},{"issue":"8902","key":"10.1016\/j.patbio.2008.02.007_bib55","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.patbio.2008.02.007_bib56","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/1097-0142(19840515)53:10<2046::AID-CNCR2820531007>3.0.CO;2-F","article-title":"Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75","volume":"53","author":"Zacharski","year":"1984","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.patbio.2008.02.007_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E","article-title":"Subcutaneous heparin treatment increases survival in small cell lung cancer. \u201cPetites Cellules\u201d Group","volume":"74","author":"Lebeau","year":"1994","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0002-9378(16)32227-X","article-title":"Anticoagulation therapy for venous thromboembolism in patients with gynecologic malignancy","volume":"147","author":"Clarke-Pearson","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"18","key":"10.1016\/j.patbio.2008.02.007_bib59","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.1976.03260440032018","article-title":"Prevention of venous thrombosis with small, subcutaneous doses of heparin","volume":"235","author":"Gallus","year":"1976","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.patbio.2008.02.007_bib60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/bjs.1800820421","article-title":"Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients","volume":"82","author":"Bergqvist","year":"1995","journal-title":"Br J Surg"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T20:55:54Z","timestamp":1588539354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811408000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0369811408000321"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2008.02.007","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}